[
  {
    "ts": null,
    "headline": "Challenges pharma companies face in push into US manufacturing",
    "summary": "Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=647e80b2671926a3baa104ef7f96ea131e061c75f5c4734f3312c9e5b565dc4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749240997,
      "headline": "Challenges pharma companies face in push into US manufacturing",
      "id": 135082821,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Yahoo Finance senior health reporter Anjalee Khemlani explains the pharmaceutical industry's push into domestic manufacturing in the US, as a reshoring tactic to tighten up the supply chain. Planning can still take several years to be finalized and face cost barriers amid tariffs. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=647e80b2671926a3baa104ef7f96ea131e061c75f5c4734f3312c9e5b565dc4d"
    }
  },
  {
    "ts": null,
    "headline": "Dow rallies 363 points on gains in shares of Chevron, Salesforce",
    "summary": "Dow rallies 363 points on gains in shares of Chevron, Salesforce",
    "url": "https://finnhub.io/api/news?id=b1d7125b855cfcaf60e936c9298ac3f908ffa8c96719900c871a6d9aaa47ced4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749210420,
      "headline": "Dow rallies 363 points on gains in shares of Chevron, Salesforce",
      "id": 135088038,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow rallies 363 points on gains in shares of Chevron, Salesforce",
      "url": "https://finnhub.io/api/news?id=b1d7125b855cfcaf60e936c9298ac3f908ffa8c96719900c871a6d9aaa47ced4"
    }
  },
  {
    "ts": null,
    "headline": "Humana: Implied Volatility Creating A Viable Investment Case",
    "summary": "Humana: Implied Volatility Creating A Viable Investment Case",
    "url": "https://finnhub.io/api/news?id=757989e823efd9e069f49d41fb3c84d09a9b1af3c2b3471fddc876348cf761c7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749209287,
      "headline": "Humana: Implied Volatility Creating A Viable Investment Case",
      "id": 135079751,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=757989e823efd9e069f49d41fb3c84d09a9b1af3c2b3471fddc876348cf761c7"
    }
  },
  {
    "ts": null,
    "headline": "Thornburg Investment Income Builder Fund Q1 2025 Commentary",
    "summary": "Thornburg Investment Income Builder Fund paid ordinary dividends of $0.24 per I share during Q1â2025, flat versus Q1â24.",
    "url": "https://finnhub.io/api/news?id=2589f9383cf86d7b276d5c426087bc24e124f08c5af2d3d742853c7cad213f70",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749198600,
      "headline": "Thornburg Investment Income Builder Fund Q1 2025 Commentary",
      "id": 135071429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155369212/image_155369212.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Thornburg Investment Income Builder Fund paid ordinary dividends of $0.24 per I share during Q1â2025, flat versus Q1â24.",
      "url": "https://finnhub.io/api/news?id=2589f9383cf86d7b276d5c426087bc24e124f08c5af2d3d742853c7cad213f70"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment",
    "summary": "Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I like BMY more than BNTX.",
    "url": "https://finnhub.io/api/news?id=40cf75ca9897f3bf3f3b4d289a9e6137b5c5103261433b512c310964b73f87be",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749193200,
      "headline": "Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment",
      "id": 135070790,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160008492/image_2160008492.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I like BMY more than BNTX.",
      "url": "https://finnhub.io/api/news?id=40cf75ca9897f3bf3f3b4d289a9e6137b5c5103261433b512c310964b73f87be"
    }
  },
  {
    "ts": null,
    "headline": "EMA PRAC's Reviewing Risk Of Encephalitis With Two Varicella Vaccines",
    "summary": "EMA: * EMA: PRAC REVIEWING RISK OF ENCEPHALITIS WITH VARICELLA VACCINES * EMA: PRAC REVIEWING KNOWN RISK OF ENCEPHALITIS WITH TWO VARICELLAVACCINES, VARILRIX AND VARIVAX...",
    "url": "https://finnhub.io/api/news?id=31cf14049c41b67613f13c23edea14bbe63bb76f9c669c1d2e35df5be356d15e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749190031,
      "headline": "EMA PRAC's Reviewing Risk Of Encephalitis With Two Varicella Vaccines",
      "id": 135070414,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "EMA: * EMA: PRAC REVIEWING RISK OF ENCEPHALITIS WITH VARICELLA VACCINES * EMA: PRAC REVIEWING KNOWN RISK OF ENCEPHALITIS WITH TWO VARICELLAVACCINES, VARILRIX AND VARIVAX...",
      "url": "https://finnhub.io/api/news?id=31cf14049c41b67613f13c23edea14bbe63bb76f9c669c1d2e35df5be356d15e"
    }
  }
]